Dirt-Cheap and Still Paying: Three Income Stocks Trading at Multi-Year Valuation Lows
Photo by Alexandra Vázquez on Unsplash
- General Mills (GIS) yields approximately 7.4% at a P/E ratio roughly 50% below its 10-year historical average — a discount rarely seen outside recessionary conditions
- Bristol Myers Squibb (BMY) offers a 4.37% dividend yield at around 9x forward earnings, sharply below the pharma sector's typical 14–16x range
- Target (TGT) yields ~3.8% at approximately 15x earnings, making it one of the cheapest large-cap retailers by valuation in the current market
- All three yield well above the S&P 500's 1.066% average as of mid-May 2026 — a spread that income-focused investors are watching closely
What's on the Table
1.066%. That is the current dividend yield of the entire S&P 500 index as of May 14, 2026 — not one stock, but 500 of America's largest companies averaged together. Data from multpl.com shows this figure sits below both the 5-year average of 1.38% and the 20-year historical average of 1.86%, meaning the broad market is offering income investors historically thin payouts by almost every measure.
Against that backdrop, Motley Fool's investment research flagged three large-cap household names in May 2026 that simultaneously yield between 3.8% and 7.4% while trading at valuations sharply compressed against their own historical norms and sector peers. Those companies: General Mills (GIS), Bristol Myers Squibb (BMY), and Target (TGT) — names recognizable from grocery aisles, medicine cabinets, and big-box retail, now appearing in a very different conversation: deeply discounted income plays.
The macro context matters here. The Federal Reserve has held its benchmark interest rate in the 3.5%–3.75% range through mid-2026, with Goldman Sachs projecting the next reductions won't arrive until December 2026 and March 2027. With PCE inflation (Personal Consumption Expenditures — the Fed's preferred gauge) hovering near 3%, bonds remain competitive with equities, which partly explains why dividend-paying stocks have been overlooked by many market participants. For those focused on yield and valuation together, however, this environment has created a window in market trends that is increasingly difficult to dismiss.
Photo by Markus Spiske on Unsplash
What the Data Tells Us
Thinking about dividend yield and P/E ratio (the stock price divided by annual earnings per share) together is like comparing a car's sticker price to what that same model normally sells for. If every comparable vehicle on the lot fetches $30,000 but one is priced at $15,000, the first question is: why? And the second is whether the answer reflects a real structural problem or simply bad press. That is the core question in any serious stock analysis of beaten-down, high-yield names.
Chart: Dividend yields for GIS, BMY, and TGT versus the S&P 500 index average as of May 14, 2026. Sources: company disclosures, multpl.com, fullratio.com.
General Mills presents the sharpest data point in this group. The company's P/E ratio stood at approximately 8.22 as of May 13, 2026, according to data compiled by fullratio.com — roughly half what the stock has historically commanded over the past decade, a 50% discount to its own 10-year average. Trailing twelve-month EPS (earnings per share) came in at $4.09 through February 2026, supporting annual dividends of $2.44 per share. That works out to a payout ratio (the percentage of earnings distributed as dividends) of 59.5% — a level that typically leaves meaningful room to sustain payments even if earnings dip modestly. The result: a yield of approximately 7.4%, or nearly seven times the S&P 500's 1.066% average — a gap that speaks volumes about current market trends in the consumer staples sector.
Bristol Myers Squibb's market trends narrative is shaped by patent anxiety. BMY trades near $57–$58.52 per share at approximately 9x forward earnings — a sharp discount to the pharma sector's typical 14–16x range. SEC Form 8-K filings show the company's 2026 total revenue guidance at $46–$47.5 billion, down from $48.2 billion in 2025. That step-down in revenue is weighing on sentiment. Yet the 4.37% yield is high for a blue-chip pharmaceutical company, and Seeking Alpha's May 2026 coverage of high-yield names cautioned that while elevated yields can reflect genuine undervaluation, investors "must verify cash flow durability and balance sheet strength" — a reasonable standard for any investment research process involving BMY.
Target's stock analysis tells a different story: a retailer with a 50-plus year track record of consecutive dividend increases, now trading at roughly 15x both trailing and forward earnings with a ~3.8% yield. The valuation is not as dramatically compressed as GIS or BMY, but within the large-cap retail universe, TGT stands out for combining reasonable earnings multiples with an exceptional dividend history at a moment when broader sentiment has depressed the sector.
Side-by-Side: How They Differ
These three stocks share the "cheap and high-yield" label, but deeper sector analysis reveals meaningfully different risk and opportunity profiles — a distinction that matters for anyone conducting rigorous investment research across these names.
General Mills (GIS) — Consumer Staples: GIS makes Cheerios, Häagen-Dazs, and Blue Buffalo pet food. The bear case is real: volume growth has stalled as shoppers trade down to store brands, and input cost inflation has squeezed margins. The bull case: the valuation implies the market has priced in persistently bad conditions for a business with decades of dividend stability. Morningstar's broader sector analysis identifies consumer staples as one of the areas where discounts to estimated fair value have widened most in 2026, with individual names reportedly trading 25%–40% below intrinsic worth estimates.
Bristol Myers Squibb (BMY) — Healthcare / Pharmaceuticals: BMY's supply chain story is built around drug patent lifecycles. Several high-revenue products face upcoming patent expirations, and the revenue guidance reduction from $48.2 billion to $46–$47.5 billion directly reflects that pressure. The counter-thesis, tracked in ongoing stock analysis: BMY has been actively acquiring late-stage pipeline assets, and the ~9x forward P/E may be pricing in a worst-case scenario that does not fully materialize. Morningstar has flagged pharmaceutical and telecom names as representing the most structurally undervalued pockets of the dividend universe heading into the second half of 2026.
Target (TGT) — Consumer Discretionary / Retail: Target's supply chain is operationally more complex — exposed to consumer spending cycles, discretionary demand patterns, and its own private-label margin mix. The ~15x P/E is the least dramatic discount of the three, but TGT's 50-plus consecutive years of dividend increases earns it Dividend King status (companies with 50 or more years of annual hikes), a designation income investors treat as evidence of management's long-term confidence in earnings durability. As Smart Finance AI noted in its analysis of ACI Worldwide's valuation gap, a strong earnings record does not automatically produce near-term stock price recognition — a pattern that TGT watchers may recognize as well.
Across all three, the unifying thread in current market trends is that the Fed's prolonged rate hold near 3.5%–3.75% has kept broad equity valuations in check, creating pockets of income opportunity in names whose business quality has historically justified far higher multiples.
Which Fits Your Situation
A 7.4% yield grabs attention, but dividend sustainability rests on free cash flow — the actual cash generated after capital expenditures. For GIS, the 59.5% payout ratio against $4.09 EPS signals genuine cushion. For BMY, investors are tracking quarterly pipeline updates to gauge whether revenues can stabilize after the projected step-down. For TGT, consumer spending data over the next two quarters will be key. Worth researching first: each company's most recent quarterly cash flow statement before completing any investment research evaluation.
A P/E at a 50% discount to historical average does not automatically mean a bargain — it may reflect the market pricing in sustained earnings pressure. The stock analysis question worth asking: is the discount pricing in a realistic headwind, or a catastrophic scenario unlikely to materialize? If earnings fall 20% but the market priced in 50%, a stock can re-rate upward even on mediocre results. This distinction separates disciplined sector analysis from yield-chasing, and it belongs at the center of any evaluation of these names.
With the Fed holding rates near 3.5%–3.75% and Goldman Sachs projecting no cuts until December 2026 at the earliest, Treasuries and high-yield savings accounts remain meaningful competition for income dollars. BMY's 4.37% yield and GIS's 7.4% yield look compelling against the S&P 500's 1.066% average, but the relevant comparison for any individual investor is against what those same dollars could earn in fixed income right now. That spread is the real measure of whether the opportunity is as substantial as the headlines suggest, and it belongs in every investment research framework for evaluating dividend stocks.
Frequently Asked Questions
Are high-yield dividend stocks like GIS and BMY worth researching when the Federal Reserve keeps interest rates elevated in 2026?
Elevated rates make bonds more competitive with dividend stocks than they were during the near-zero rate era. However, GIS and BMY are currently yielding well above most fixed-income alternatives. The core stock analysis question is whether those dividends rest on durable cash flows. For GIS, the 59.5% payout ratio against $4.09 in trailing EPS suggests real cushion. For BMY, pipeline developments and quarterly cash generation are the key variables to monitor. Rate pressure is a genuine headwind, but deeply compressed valuations can offset that risk if the underlying business holds — making both names worth researching carefully before drawing conclusions.
What does a P/E ratio 50% below its historical average actually mean for General Mills stock in the current market?
A P/E ratio (the stock price divided by annual earnings per share) that sits 50% below a company's 10-year average signals the market expects materially worse conditions ahead than history has typically delivered. For GIS, this has been driven by private-label competition and volume pressure across core food categories. The central investment research question: does the discount reflect a structural industry shift, or temporary headwinds? The 59.5% payout ratio suggests dividends have room to absorb moderate earnings pressure, but forward earnings trajectories are worth researching independently through company filings and analyst estimates before reaching a verdict.
How does Target's 3.8% dividend yield compare to other large-cap retailers in 2026, and is the payout actually sustainable?
Target's ~3.8% yield at approximately 15x earnings places it among the most attractively valued large-cap retailers on a combined yield-and-valuation basis. Most major retail peers either yield less, trade at higher multiples, or both. TGT's Dividend King status — earned through 50-plus consecutive years of annual increases — carries particular weight in income-focused sector analysis. That said, retail sector analysis in mid-2026 requires close attention to consumer spending trends and TGT's competitive positioning against Amazon and Walmart. The dividend looks historically well-covered, but forward conditions warrant monitoring closely.
Is Bristol Myers Squibb's 4.37% dividend yield genuinely sustainable given the projected revenue decline in its 2026 guidance?
BMY's own guidance projects 2026 total revenue of $46–$47.5 billion, down from $48.2 billion in 2025 — a real headwind disclosed in SEC Form 8-K filings. The investment research question is whether that decline is already reflected in the ~9x forward P/E, or whether additional earnings pressure lies ahead. Seeking Alpha's May 2026 sector coverage cautioned that high yields "aren't always sustainable" and that cash flow strength must be independently verified. Many analysts currently view BMY's dividend as covered by free cash flow, but pipeline news and quarterly results over the coming year are essential tracking points.
Why is the S&P 500 dividend yield so far below individual stocks like GIS and BMY — and does that gap signal a shift in broader market trends?
The S&P 500's 1.066% yield as of May 14, 2026 reflects the index's heavy weighting toward technology and growth companies that reinvest earnings rather than distribute them — names like Nvidia, Meta, and Alphabet. When GIS yields 7.4%, that represents approximately seven times the broad market average. This divergence is part of what makes current market trends notable for income investors: the spread between the cheapest, highest-yielding large-cap names and the index average has widened to levels not commonly seen in recent years. Whether that gap closes through dividend stock re-rating or continued index appreciation is a question that sector analysts are watching closely heading into the second half of 2026.
Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always do your own research and consult a licensed financial advisor before making investment decisions.
Get NewsLens — All 19 Channels in One App
AI-powered news with action steps. Install free, works offline.
No comments:
Post a Comment